REGENERON PHARMACEUTICALS, INC. Financing Cash Flow 2008-2026 | REGN
Beta
What is financing cash flow?
Financing cash flow represents cash from or used in financing activities, including borrowing, repaying debt, issuing or repurchasing stock, and paying dividends.
What is REGENERON PHARMACEUTICALS, INC.'s current financing cash flow?
REGENERON PHARMACEUTICALS, INC. (REGN) annual financing cash flow for 2025 was $-3.72B, a 68.84% decline from 2024. REGENERON PHARMACEUTICALS, INC. financing cash flow for the quarter ending March 31, 2026 was $-802.2M.
What was REGENERON PHARMACEUTICALS, INC.'s financing cash flow in 2024?
REGENERON PHARMACEUTICALS, INC. annual financing cash flow for 2024 was $-2.20B, a 22.93% decline from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s financing cash flow in 2023?
REGENERON PHARMACEUTICALS, INC. annual financing cash flow for 2023 was $-1.79B, a 77.41% decline from 2022.
Financing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGRN/A
FY2020
$-1.97B
→
FY2025
$-3.72B
080910111213141516171819202122232425
5 years selected
Financing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-3.72B | -68.8% | 10-K |
| FY2024 | $-2.20B | -22.9% | 10-K |
| FY2023 | $-1.79B | -77.4% | 10-K |
| FY2022 | $-1.01B | -0.3% | 10-K |
| FY2021 | $-1.01B | +49.0% | 10-K |
| FY2020 | $-1.97B | -681.6% | 10-K |
| FY2019 | $-252.1M | -227.0% | 10-K |
| FY2018 | $-77.1M | -216.0% | 10-K |
| FY2017 | $-24.4M | +96.5% | 10-K |
| FY2016 | $-700.5M | -166.6% | 10-K |
| FY2015 | $-262.8M | -20.2% | 10-K |
| FY2014 | $-218.5M | -402.7% | 10-K |
| FY2013 | $72.2M | +173.9% | 10-K |
| FY2012 | $-97.6M | -125.4% | 10-K |
| FY2011 | $384.2M | +57.9% | 10-K |
| FY2010 | $243.3M | +675.8% | 10-K |
| FY2009 | $31.4M | +116.3% | 10-K |
| FY2008 | $-192.9M | - | 10-K |
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →